
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited EV 2011-2026 | QTNT
EV Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 393 M | 892 M | 632 M | 289 M | 321 M | 235 M | 255 M | 184 M | 31.7 M | 31 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 892 M | 31 M | 326 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 119.77 | -0.5 % | $ 36.4 B | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 20.56 | 3.37 % | $ 221 M | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 17.57 | -0.34 % | $ 936 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.42 | 2.9 % | $ 1.89 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 24.62 | 1.03 % | $ 684 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 180.56 | 0.7 % | $ 8.95 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
145 B | $ 198.14 | -0.2 % | $ 141 B | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
15.3 B | $ 132.26 | 1.49 % | $ 21 B | ||
|
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 29.09 | - | $ 20 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 16.17 | 0.94 % | $ 489 M | ||
|
Guardant Health
GH
|
15.2 B | $ 84.86 | -1.78 % | $ 10.6 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
990 K | $ 2.93 | 1.74 % | $ 95.1 K | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.11 | 0.48 % | $ 4.85 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 518.54 | -0.28 % | $ 15 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 116.5 | 3.04 % | $ 9.61 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 266.73 | -0.8 % | $ 22.2 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
5.57 B | $ 123.47 | 2.17 % | $ 5.77 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 5.19 | 5.7 % | $ 481 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 83.94 | 1.45 % | $ 5.67 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.68 | 3.95 % | $ 1.11 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.42 | -1.98 % | $ 2.04 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 191.42 | -1.41 % | $ 21.2 B | ||
|
ENDRA Life Sciences
NDRA
|
4.49 M | $ 5.14 | 3.63 % | $ 4.05 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
National Research Corporation
NRC
|
432 M | $ 17.84 | 4.69 % | $ 399 M | ||
|
Natera
NTRA
|
5.53 B | $ 207.19 | -3.47 % | $ 20.4 B | ||
|
OpGen
OPGN
|
10.3 M | - | -16.95 % | $ 1.54 M | ||
|
Organovo Holdings
ONVO
|
-4.05 M | - | -2.3 % | $ 19.4 M | ||
|
Psychemedics Corporation
PMD
|
20.5 M | - | -1.84 % | $ 15.3 M |